Transplant Immunology
Scope & Guideline
Unveiling the Complexities of Immunological Mechanisms in Transplantation.
Introduction
Aims and Scopes
- Transplant Rejection Mechanisms:
The journal explores the cellular and molecular mechanisms underlying both acute and chronic rejection in solid organ and hematopoietic stem cell transplants, providing insights into immune responses and their modulation. - Immunosuppressive Strategies:
Research on various immunosuppressive regimens, including the efficacy and safety of novel agents, is a core focus. The journal evaluates the impact of these therapies on transplant outcomes and patient survival. - Infection and Immunity:
The relationship between infections, particularly viral infections like CMV and COVID-19, and their effects on transplant recipients' immune response is a significant area of investigation. - Biomarkers and Diagnostics:
The identification and validation of biomarkers for predicting transplant outcomes, rejection, and complications are emphasized, aiding in the development of personalized medicine approaches. - Cell Therapy and Regenerative Medicine:
The application of stem cell therapies and regenerative medicine techniques in improving transplant outcomes and managing rejection is increasingly featured in the journal. - Ethical and Societal Issues in Transplantation:
The journal also addresses ethical considerations and societal impacts of organ transplantation, including donor-recipient matching, allocation policies, and public perceptions.
Trending and Emerging
- COVID-19 and Transplantation:
The impact of COVID-19 on transplant recipients, including vaccination responses and infection management, has become a prominent theme, reflecting the pandemic's influence on healthcare. - Machine Learning and Bioinformatics:
The integration of machine learning and bioinformatics in predicting transplant outcomes and personalizing immunosuppressive therapy is gaining traction, indicating a shift towards data-driven approaches in transplantation. - Microbiome and Immune Interactions:
Research exploring the role of the gut microbiome in modulating immune responses in transplant recipients is emerging, highlighting the importance of microbial health in transplantation. - Cell-Based Therapies:
The use of cell-based therapies, particularly involving mesenchymal stem cells and regulatory T cells, is increasingly featured, indicating a growing interest in regenerative approaches to manage rejection. - Longitudinal Studies and Real-World Data:
There is a rising emphasis on longitudinal studies and the use of real-world data to assess long-term outcomes and complications post-transplantation, providing a more comprehensive understanding of transplant success.
Declining or Waning
- Traditional Immunosuppressive Agents:
Research focusing solely on traditional immunosuppressive agents like calcineurin inhibitors has seen a decline as newer, more targeted therapies gain interest and application in clinical settings. - Generalized Risk Factors for Rejection:
While risk factors for transplant rejection remain important, the focus has shifted towards more specific biomarkers and mechanistic studies rather than broad, generalized factors. - Descriptive Case Reports:
While case reports are valuable, there is a noticeable decrease in the publication of purely descriptive case reports, with a preference for studies that provide mechanistic insights or larger cohort analyses.
Similar Journals
International Journal of Organ Transplantation Medicine
Pioneering Discoveries in Organ TransplantationThe International Journal of Organ Transplantation Medicine, published by the Avicenna Organ Transplant Center, stands as a vital resource for the field of transplantation medicine. Established to advance scientific knowledge and clinical practices, this open access journal has been supporting the global research community since 2010, ensuring that groundbreaking findings are easily accessible to researchers, professionals, and students alike. With its ISSN of 2008-6490 and E-ISSN 2008-6482, the journal consistently showcases high-quality, peer-reviewed articles, addressing critical advancements in transplantation techniques, patient care, and immunology. Renowned for its commitment to excellence, it holds a Q3 ranking in transplantation for 2023 and ranks #32 out of 54 in the Scopus medicine transplantation category, placing it in the 41st percentile. Researchers are encouraged to submit their work, contributing to the journal's goal of improving outcomes in organ transplantation and fostering collaboration across disciplines.
AMERICAN JOURNAL OF TRANSPLANTATION
Advancing transplantation science for a healthier tomorrow.American Journal of Transplantation, published by Elsevier Science Inc, is a premier academic journal dedicated to the critical field of transplantation. With an impressive impact factor and prestigious rankings in Immunology and Allergy, Pharmacology (medical), and Transplantation, it stands as a leading source of high-quality research in these domains, boasting a Q1 category status since 2023. The journal serves an essential role in advancing scientific knowledge and clinical practices, publishing cutting-edge studies that address pressing issues in organ transplantation and immunology. Researchers, healthcare professionals, and students will find valuable insights through rigorous peer-reviewed articles that focus on innovative methodologies, outcomes, and the latest developments within transplantation science. As the journal continues to evolve from its inception in 2001 to its ongoing contributions through 2024, it remains a key resource for those looking to stay at the forefront of transplantation research and practice.
TRANSPLANTATION
Elevating Standards in Organ Transplantation Research.TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.
Current Transplantation Reports
Navigating the Evolving Landscape of Transplant ScienceCurrent Transplantation Reports, published by SpringerNature, is a leading journal in the field of transplantation science, offering vital insights into the cutting-edge developments in transplant medicine and related disciplines. With an impressive array of quartile rankings, including Q2 in Nephrology and Transplantation, and Q3 in Hepatology and Immunology for 2023, this journal plays a significant role in bridging research and clinical practice. Focused on fostering innovation, the journal spans a wide spectrum of topics, from surgical advances to immunological considerations of transplant procedures. It serves as an invaluable resource for researchers, healthcare professionals, and students interested in the latest advancements and data in transplantation, recognizing the importance of disseminating knowledge in this evolving field. Although currently not designated as Open Access, it provides rigorous peer-reviewed articles that contribute to the academic community's understanding of transplantation scenarios and challenges faced in clinical settings.
XENOTRANSPLANTATION
Catalyzing Breakthroughs in Transplant ScienceXENOTRANSPLANTATION is a premier journal published by Wiley, dedicated to advancing the field of transplant medicine and immunology. Since its inception in 1994, this journal has provided a vital platform for researchers to disseminate groundbreaking studies and reviews, focusing on the complexities of xenotransplantation—the transplantation of organs and tissues from one species to another. With an impressive impact factor emphasizing its relevance, it has garnered recognition in the 2023 rankings, achieving Q1 status in the field of Transplantation and Q2 in Immunology. This positions it among the top journals, ranked #12 out of 54 in Transplantation and #102 out of 236 in Immunology, according to Scopus metrics. Despite being a subscription-based journal, its commitment to high-quality research ensures that it remains essential for professionals, researchers, and students seeking to innovate and facilitate progress in the increasingly critical area of organ transplantation. XENOTRANSPLANTATION is not just a journal; it is a crucial resource for fostering collaboration and knowledge in a field that continually shapes the future of medicine.
Annals of Transplantation
Elevating Standards in Transplantation PracticesAnnals of Transplantation is a renowned academic journal published by INT SCIENTIFIC INFORMATION, INC, dedicated to the field of transplantation medicine. With a strong historical presence since its inception in 1996, this journal continues to provide a vital platform for disseminating innovative research, clinical studies, and review articles that contribute significantly to the ever-evolving landscape of organ transplantation. Holding a respectable Q2 ranking in the field of transplantation and a Q3 ranking in broader medicine categories as of 2023, the journal stands out with an impactful repository of knowledge that caters to a diverse audience, including researchers, healthcare professionals, and students. While it currently does not operate under an open access model, the scholarly contributions within are crucial for advancing practices, policies, and outcomes in transplantation. Whether you are seeking to keep abreast of recent advances or looking to publish your own findings, Annals of Transplantation serves as an essential resource for fostering collaboration and innovation in medical science.
CANCER IMMUNOLOGY IMMUNOTHERAPY
Exploring Innovative Therapies for Cancer PatientsCancer Immunology Immunotherapy, published by Springer, stands as a premier journal in the fields of cancer research and immunology, holding a prestigious Q1 ranking across multiple categories, including Oncology and Medicine as of 2023. With an ISSN of 0340-7004 and an E-ISSN of 1432-0851, this journal has been a pivotal platform for groundbreaking research since its inception in 1976, continuing to provide insight into the complex interactions between the immune system and cancer. The journal's scope encompasses a wide array of topics, including novel therapeutic strategies, immunological mechanisms, and translational science aimed at advancing treatment outcomes for cancer patients. Renowned for its rigorous peer-review process and high impact factor, it attracts contributions from leading experts and researchers around the globe, positioning itself among the top-tier publications with Scopus rankings that reflect its vital role in advancing the field. Access options are generally subscription-based, ensuring a comprehensive resource for professionals and academics seeking to deepen their understanding and make meaningful contributions to cancer immunotherapy.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
Championing Life-Saving Advances in Heart and Lung HealthJOURNAL OF HEART AND LUNG TRANSPLANTATION, published by Elsevier Science Inc., serves as a premier platform for researchers and clinicians in the fields of Cardiology, Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery, and Transplantation. Since its inception in 1991, this esteemed journal has maintained a robust impact within the scientific community, currently holding a remarkable Q1 ranking in multiple categories as of 2023, indicative of its influential contributions to the field. With Scopus rankings placing it among the top ten in Surgery and fourth in Transplantation, it is essential reading for those looking to stay at the forefront of innovative transplantation techniques and cardiovascular research. Although not an open access journal, its rich content is crucial for advancing knowledge and promoting best practices, making it indispensable for professionals, students, and researchers dedicated to the life-saving field of heart and lung transplantation. The journal continues to foster academic excellence and facilitate impactful research, addressing contemporary challenges and innovations within these critical areas.
Vestnik Transplantologii i Iskusstvennyh Organov
Advancing the frontiers of transplantation and immunology.Vestnik Transplantologii i Iskusstvennyh Organov, published by the Federal Research Center Transplantology & Artificial Organs V I Shumakov, is an esteemed open access journal that has been disseminating critical research in the fields of transplantation and immunology since 2009. With an ISSN of 1995-1191 and E-ISSN 2412-6160, this journal serves as a vital resource for academics and practitioners alike, offering insights into current trends, innovations, and methodologies in organ transplantation. The journal is indexed in prominent databases, holding a Q4 category in Immunology and Allergy and a Q3 in Transplantation as of 2023, ranking 42nd out of 54 in the field of Medicine - Transplantation, and 208th out of 233 in Medicine - Immunology and Allergy. Through its commitment to open access publishing and its strategic focus on advancing the science of transplantology, Vestnik Transplantologii i Iskusstvennyh Organov contributes significantly to the global body of knowledge, promoting collaboration and engagement among researchers, healthcare professionals, and students from around the world.
Transplantation Reviews
Elevating surgical practices with expert insights and reviews.Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.